May 7, 2020 – Topline results from HighTide Therapeutics’s HTD1801 NASH study.

article-05-07-2020

Results showed a statistical significant reduction in liver fat in patients with NASH and diabetes. Our contribution to this important study is what makes us proud of what we do!
https://www.businesswire.com/news/home/20200507005019/en/HighTide-Therapeutics-Announces-Positive-Topline-Results-Phase

/ Uncategorized
  • Next Post
  • Previous Post
SIGN UP NOW

Click here to participate in a study

NRI CLINICS ARE CURRENTLY OPEN!
X